Haïssaguerre Michel, Hocini Mélèze, Sanders Prashanthan, Sacher Frederic, Rotter Martin, Takahashi Yoshihide, Rostock Thomas, Hsu Li-Fern, Bordachar Pierre, Reuter Sylvain, Roudaut Raymond, Clémenty Jacques, Jaïs Pierre
Hôpital Cardiologique du Haut-Lévêque, Bordeaux-Pessac, France.
J Cardiovasc Electrophysiol. 2005 Nov;16(11):1138-47. doi: 10.1111/j.1540-8167.2005.00308.x.
Catheter ablation of atrial fibrillation (AF) is challenging in patients with long-standing persistent AF. The clinical outcome and subsequent arrhythmia recurrence after using an ablation method targeting multiple left atrial sites with the aim of achieving acute AF termination has not been characterized.
Sixty patients (mean age: 53 +/- 9 years) with persistent AF (mean duration: 17 +/- 27 months) were prospectively followed after catheter ablation. Catheter ablation targeting the following sites was performed in a random sequence: (i) electrical isolation of all pulmonary veins (PV); (ii) disconnection of other thoracic veins; (iii) atrial ablation at sites possessing complex electrical activity, activation gradients, or short cycle lengths. Finally, linear ablation of the LA roof and mitral isthmus was performed if sinus rhythm was not restored following energy delivery to the above sites. At 1, 3, 6, and 12 months after ablation, patients underwent clinical review and 24-hour ambulatory ECG monitoring to identify asymptomatic arrhythmia. Repeat mapping and catheter ablation was performed in any patient experiencing recurrent atrial tachycardia (AT). Clinical success was defined as the absence of any sustained atrial arrhythmia.
AF terminated during ablation in 52 patients (87%). The fluoroscopy and procedural durations were 84 +/- 30 minutes and 264 +/- 77 minutes, respectively. Three months after ablation, sustained ATs were documented in 24 patients (associated with AF in 2). Mapping in 23 patients showed a single AT in 7 while multiple ATs were observed in 16. Macroreentry was confirmed to be due to gaps in the ablation lines, while focal ATs originated from discrete sites or isthmuses near the left atrial appendage, coronary sinus, pulmonary veins, or fossa ovalis; these sites were similar to those at which the greatest impact was observed on the fibrillatory process during the initial ablation procedure. After repeat ablation, at 11 +/- 6 months of follow-up, 57 patients (95%) were in sinus rhythm and 3 developed recurrent AF or AT. All patients in sinus rhythm demonstrated improved exercise capacity and all but 2 had evidence of atrial transport as assessed by Doppler echocardiography (mitral A wave velocity 34 +/- 17 cm/sec) by 6 months.
Catheter ablation of long-lasting persistent AF associated with acute AF termination achieves medium to long-term restoration and maintenance of sinus rhythm in 95% of patients. Arrhythmia recurrence in the majority of patients is AT.
对于长期持续性心房颤动(AF)患者,导管消融治疗具有挑战性。采用针对多个左心房部位的消融方法以实现急性房颤终止后的临床结局及随后的心律失常复发情况尚未得到明确描述。
对60例持续性房颤患者(平均年龄:53±9岁,平均病程:17±27个月)进行导管消融术后的前瞻性随访。以随机顺序对以下部位进行导管消融:(i)所有肺静脉(PV)电隔离;(ii)其他胸段静脉离断;(iii)在具有复杂电活动、激动梯度或短周期长度的部位进行心房消融。最后,如果在对上述部位进行能量释放后未恢复窦性心律,则进行左心房顶部和二尖瓣峡部的线性消融。在消融后1、3、6和12个月,患者接受临床检查及24小时动态心电图监测以识别无症状性心律失常。对任何发生复发性房性心动过速(AT)的患者进行重复标测和导管消融。临床成功定义为无任何持续性房性心律失常。
52例患者(87%)在消融过程中房颤终止。透视时间和手术时间分别为84±30分钟和264±77分钟。消融后3个月,24例患者记录到持续性房性心动过速(2例与房颤相关)。23例患者的标测显示,7例为单一房性心动过速,16例为多个房性心动过速。证实大折返是由于消融线存在间隙,而局灶性房性心动过速起源于左心耳、冠状窦、肺静脉或卵圆窝附近的离散部位或峡部;这些部位与在初始消融过程中对颤动过程影响最大的部位相似。重复消融后,在随访11±6个月时,57例患者(95%)处于窦性心律,3例发生复发性房颤或房性心动过速。所有处于窦性心律的患者运动能力均有所改善,到6个月时,除2例患者外,所有患者经多普勒超声心动图评估(二尖瓣A波速度34±17cm/秒)均有房内传输证据。
与急性房颤终止相关的长期持续性房颤导管消融可使95%的患者实现中长期窦性心律的恢复和维持。大多数患者的心律失常复发为房性心动过速。